<SEC-DOCUMENT>0001193125-20-071623-index.html : 20200312
<SEC-HEADER>0001193125-20-071623.hdr.sgml : 20200312
<ACCEPTANCE-DATETIME>20200312162806
ACCESSION NUMBER:		0001193125-20-071623
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20200312
DATE AS OF CHANGE:		20200312
GROUP MEMBERS:		BCIP LIFE SCIENCES ASSOCIATES, LP

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DYNAVAX TECHNOLOGIES CORP
		CENTRAL INDEX KEY:			0001029142
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				330728374
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-80035
		FILM NUMBER:		20709169

	BUSINESS ADDRESS:	
		STREET 1:		2929 SEVENTH STREET
		STREET 2:		SUITE 100
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
		BUSINESS PHONE:		5108485100

	MAIL ADDRESS:	
		STREET 1:		2929 SEVENTH STREET
		STREET 2:		SUITE 100
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bain Capital Life Sciences Fund, L.P.
		CENTRAL INDEX KEY:			0001687968
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		200 CLARENDON STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		617-516-2000

	MAIL ADDRESS:	
		STREET 1:		200 CLARENDON STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>d898924dsc13da.htm
<DESCRIPTION>SC 13D/A
<TEXT>
Document 1 - file: d898924dsc13da.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.D
<SEQUENCE>2
<FILENAME>d898924dex99d.htm
<DESCRIPTION>EX-99.D
<TEXT>
Document 2 - file: d898924dex99d.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.E
<SEQUENCE>3
<FILENAME>d898924dex99e.htm
<DESCRIPTION>EX-99.E
<TEXT>
Document 3 - file: d898924dex99e.htm

</DOCUMENT>
</SEC-DOCUMENT>